Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization

Conditions:   Oral Cavity Cancer;   Mouth Neoplasm;   Precancerous Conditions Intervention:   Drug: Sintilimab Sponsor:   Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials